Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sorrento Therapeutics Inc
(NQ:
SRNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sorrento Therapeutics Inc
MarketBeat: Week in Review 01/09-01/13
January 14, 2023
Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
January 12, 2023
Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to market
Via
MarketBeat
3 Biotech Stocks Gaining Momentum
September 12, 2022
The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power.
Via
MarketBeat
Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players
March 24, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2022 – USA News Group – Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight...
Via
FinancialNewsMedia
Exposures
COVID-19
Introduction of Innovative PCR-Based Detection Methods Surges Fueled by Pandemic and Other Diseases
February 18, 2022
Palm Beach, FL – February 18, 2022 – FinancialNewsMedia.com News Commentary – PCR testing and the COVID-19 diagnostic testing market has, unexpectantly, been growing at a substantial rate the past few...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Newman Ferrara LLP Announces Corporate Governance Investigation of Sorrento Therapeutics, Inc. – SRNE
January 31, 2022
From
Newman Ferrara LLP
Via
Business Wire
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
December 07, 2021
Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not...
Via
FinancialNewsMedia
Exposures
COVID-19
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
September 28, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Global COVID-19 Therapeutics Market Size Now Expected To Exceed $25 Billion In 2030
November 09, 2021
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result in the...
Via
FinancialNewsMedia
Topics
Death
Exposures
COVID-19
Death
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market
June 03, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
October 20, 2021
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...
Via
FinancialNewsMedia
Exposures
COVID-19
SORRENTO INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
April 09, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
September 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients
September 14, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
July 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.